{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T14:58:29Z","timestamp":1791644309603,"version":"4.3.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T00:00:00Z","timestamp":1573516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T00:00:00Z","timestamp":1573516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2018R1D1A1B07044100"],"award-info":[{"award-number":["2018R1D1A1B07044100"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Psoriasis is a chronic inflammatory skin disorder mediated by the T-cell\u2013related immune response. Psoriatic patients may have a variety of comorbidities, but their risk of end-stage renal disease (ESRD), particularly according to the subtype of psoriasis, is unclear. We investigated the risk of ESRD in patients with psoriasis according to the subtype of psoriasis and history of systemic therapy for psoriasis. A total of 2,121,228 adults (1,590,921 in the control group and 530,307 in the psoriasis group) were enrolled in this nationwide population-based cohort study until 2015. During follow-up, 1,434 of the subjects in the psoriasis group developed ESRD. After adjusting for confounding factors, psoriasis was associated with the risk of ESRD (hazard ratio (HR) 1.58, 95% confidence interval [95% CI] 1.47\u20131.68). The psoriatic arthritis group (HR 7.60, 95% CI 1.90\u201330.41) had a higher risk of ESRD than the control group. Interestingly, no such association was detected in the systemically treated group (HR 1.07, 95% CI 0.80\u20131.41). Moreover, the acitretin-treated group had a lower risk of ESRD (HR 0.658, 95% CI, 0.494\u20130.875) than the non-systemically treated group. In conclusion, the risk of developing ESRD in patients with psoriasis differed according to the type of treatment and the presence of arthritis.<\/jats:p>","DOI":"10.1038\/s41598-019-53017-4","type":"journal-article","created":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T06:03:18Z","timestamp":1573538598000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Risk of End-Stage Renal Disease in Psoriatic Patients: Real-World Data from a Nationwide Population-Based Cohort Study"],"prefix":"10.1038","volume":"9","author":[{"given":"Eun","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju Hee","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6246-0331","authenticated-orcid":false,"given":"Chul Hwan","family":"Bang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Ah","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Do","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ha-Na","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Min","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3671-502X","authenticated-orcid":false,"given":"Ji Hyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,12]]},"reference":[{"issue":"5","key":"53017_CR1","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1056\/NEJMra0804595","volume":"361","author":"FO Nestle","year":"2009","unstructured":"Nestle, F. O., Kaplan, D. H. & Barker, J. Psoriasis. N Engl J Med 361(5), 496\u2013509 (2009).","journal-title":"N Engl J Med"},{"issue":"1","key":"53017_CR2","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1111\/bjd.15610","volume":"177","author":"CEM Griffiths","year":"2017","unstructured":"Griffiths, C. E. M. et al. The global state of psoriasis disease epidemiology: a workshop report. Br J Dermatol 177(1), e4\u2013e7 (2017).","journal-title":"Br J Dermatol"},{"issue":"3","key":"53017_CR3","doi-asserted-by":"publisher","first-page":"262","DOI":"10.2340\/00015555-0642","volume":"89","author":"YT Chang","year":"2009","unstructured":"Chang, Y. T. et al. Epidemiological study of psoriasis in the national health insurance database in Taiwan. Acta dermato-venereologica 89(3), 262\u20136 (2009).","journal-title":"Acta dermato-venereologica"},{"key":"53017_CR4","doi-asserted-by":"crossref","unstructured":"Oh, E., H., Ro, Y. S. & Kim, J. E. Epidemiology and cardiovascular comorbidities in patients with psoriasis: A Korean nationwide population-based cohort study. J Dermatol (2017).","DOI":"10.1111\/1346-8138.13761"},{"issue":"1","key":"53017_CR5","doi-asserted-by":"publisher","first-page":"e006450","DOI":"10.1136\/bmjopen-2014-006450","volume":"5","author":"K Kubota","year":"2015","unstructured":"Kubota, K. et al. Epidemiology of psoriasis and palmoplantar pustulosis: a nationwide study using the Japanese national claims database. BMJ Open 5(1), e006450 (2015).","journal-title":"BMJ Open"},{"issue":"5","key":"53017_CR6","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1684\/ejd.2012.1802","volume":"22","author":"X Ding","year":"2012","unstructured":"Ding, X. et al. Prevalence of psoriasis in China: a population-based study in six cities. Eur J Dermatol 22(5), 663\u20137 (2012).","journal-title":"Eur J Dermatol"},{"issue":"4","key":"53017_CR7","doi-asserted-by":"publisher","first-page":"396","DOI":"10.2340\/00015555-2877","volume":"98","author":"JH Han","year":"2018","unstructured":"Han, J. H. et al. Epidemiology and Medication Trends in Patients with Psoriasis: A Nationwide Population-based Cohort Study from Korea. Acta Derm Venereol 98(4), 396\u2013400 (2018).","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"53017_CR8","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s00403-016-1712-1","volume":"309","author":"L Raaby","year":"2017","unstructured":"Raaby, L., Ahlehoff, O. & de Thurah, A. Psoriasis and cardiovascular events: updating the evidence. Arch Dermatol Res 309(3), 225\u20138 (2017).","journal-title":"Arch Dermatol Res"},{"issue":"4","key":"53017_CR9","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1600-0625.2011.01261.x","volume":"20","author":"WH Boehncke","year":"2011","unstructured":"Boehncke, W. H., Boehncke, S., Tobin, A. M. & Kirby, B. The \u2018psoriatic march\u2019: a concept of how severe psoriasis may drive cardiovascular comorbidity. Exp Dermatol 20(4), 303\u20137 (2011).","journal-title":"Exp Dermatol"},{"issue":"8","key":"53017_CR10","doi-asserted-by":"publisher","first-page":"e0202854","DOI":"10.1371\/journal.pone.0202854","volume":"13","author":"HN Kim","year":"2018","unstructured":"Kim, H. N., Han, K., Song, S. W. & Lee, J. H. Hypertension and risk of psoriasis incidence: An 11-year nationwide population-based cohort study. PLoS One 13(8), e0202854 (2018).","journal-title":"PLoS One"},{"issue":"1","key":"53017_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-10556-y","volume":"7","author":"TM Rhee","year":"2017","unstructured":"Rhee, T. M. et al. Increased Risk of Atrial Fibrillation and Thromboembolism in Patients with Severe Psoriasis: a Nationwide Population-based Study. Sci Rep 7(1), 9973 (2017).","journal-title":"Sci Rep"},{"issue":"4","key":"53017_CR12","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.jaad.2017.04.1133","volume":"77","author":"MJM Rodriguez-Zuniga","year":"2017","unstructured":"Rodriguez-Zuniga, M. J. M. & Garcia-Perdomo, H. A. Systematic review and meta-analysis of the association between psoriasis and metabolic syndrome. J Am Acad Dermatol 77(4), 657\u201366 e8 (2017).","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"53017_CR13","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.jaad.2006.08.040","volume":"55","author":"AL Neimann","year":"2006","unstructured":"Neimann, A. L. et al. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 55(5), 829\u201335 (2006).","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"53017_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-27147-0","volume":"8","author":"JH Lee","year":"2018","unstructured":"Lee, J. H. et al. Psoriasis risk in patients with diabetic retinopathy: A nationwide population-based study. Sci Rep 8(1), 9086 (2018).","journal-title":"Sci Rep"},{"issue":"5","key":"53017_CR15","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1111\/j.1365-2133.2011.10494.x","volume":"165","author":"YW Yang","year":"2011","unstructured":"Yang, Y. W., Keller, J. J. & Lin, H. C. Medical comorbidity associated with psoriasis in adults: a population-based study. Br J Dermatol 165(5), 1037\u201343 (2011).","journal-title":"Br J Dermatol"},{"issue":"9","key":"53017_CR16","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1111\/1346-8138.14531","volume":"45","author":"CC Wang","year":"2018","unstructured":"Wang, C. C., Tang, C. H., Huang, K. C., Huang, S. Y. & Sue, Y. M. Increased risk of incident psoriasis in end-stage renal disease patients on chronic hemodialysis: A nationwide population-based cohort study. J Dermatol 45(9), 1063\u201370 (2018).","journal-title":"J Dermatol"},{"key":"53017_CR17","doi-asserted-by":"publisher","first-page":"f5961","DOI":"10.1136\/bmj.f5961","volume":"347","author":"J Wan","year":"2013","unstructured":"Wan, J. et al. Risk of moderate to advanced kidney disease in patients with psoriasis: population based cohort study. BMJ 347, f5961 (2013).","journal-title":"BMJ"},{"issue":"3","key":"53017_CR18","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jdermsci.2015.03.012","volume":"78","author":"CC Chi","year":"2015","unstructured":"Chi, C. C. et al. Risk of incident chronic kidney disease and end-stage renal disease in patients with psoriasis: A nationwide population-based cohort study. J Dermatol Sci 78(3), 232\u20138 (2015).","journal-title":"J Dermatol Sci"},{"issue":"1","key":"53017_CR19","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/bjd.13599","volume":"173","author":"HY Chiu","year":"2015","unstructured":"Chiu, H. Y. et al. Increased risk of glomerulonephritis and chronic kidney disease in relation to the severity of psoriasis, concomitant medication, and comorbidity: a nationwide population-based cohort study. Br J Dermatol 173(1), 146\u201354 (2015).","journal-title":"Br J Dermatol"},{"issue":"9997","key":"53017_CR20","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","volume":"386","author":"WH Boehncke","year":"2015","unstructured":"Boehncke, W. H. & Schon, M. P. Psoriasis. Lancet 386(9997), 983\u201394 (2015).","journal-title":"Lancet"},{"key":"53017_CR21","doi-asserted-by":"crossref","unstructured":"Lee, J. H, et al. Cancer risk in 892 089 patients with psoriasis in Korea: A nationwide population-based cohort study. J Dermatol (2018).","DOI":"10.1111\/1346-8138.14698"},{"key":"53017_CR22","unstructured":"Lee, J. H., Han, K. & Gee, H. Y. The Incidence Rates and Risk Factors of Parkinson\u2019s Disease in Patients with Psoriasis: A Nationwide Population-based Cohort Study. J Am Acad Dermatol (2019)."},{"key":"53017_CR23","doi-asserted-by":"crossref","unstructured":"Bang, C. H., et al. Association of Psoriasis With Mental Health Disorders in South Korea. JAMA Dermatol (2019).","DOI":"10.1001\/jamadermatol.2019.0315"},{"issue":"2","key":"53017_CR24","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s11255-011-9966-1","volume":"44","author":"E Dervisoglu","year":"2012","unstructured":"Dervisoglu, E., Akturk, A. S., Yildiz, K., Kiran, R. & Yilmaz, A. The spectrum of renal abnormalities in patients with psoriasis. Int Urol Nephrol 44(2), 509\u201314 (2012).","journal-title":"Int Urol Nephrol"},{"issue":"3","key":"53017_CR25","first-page":"382","volume":"19","author":"J Zadrazil","year":"2006","unstructured":"Zadrazil, J. et al. IgA nephropathy associated with psoriasis vulgaris: a contribution to the entity of \u2018psoriatic nephropathy\u2019. J Nephrol 19(3), 382\u20136 (2006).","journal-title":"J Nephrol"},{"issue":"1","key":"53017_CR26","first-page":"63","volume":"42","author":"T Kaji","year":"1994","unstructured":"Kaji, T. et al. Membranous nephropathy associated with psoriasis vulgaris. Clin Nephrol 42(1), 63\u20134 (1994).","journal-title":"Clin Nephrol"},{"issue":"6","key":"53017_CR27","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1046\/j.1468-3083.2000.00119.x","volume":"14","author":"JC Szepietowski","year":"2000","unstructured":"Szepietowski, J. C., Bielicka, E., Wasik, F., Kopec, W. & Szepietowski, T. Microalbuminuria as a subclinical marker of renal impairment in subjects with psoriasis vulgaris. J Eur Acad Dermatol Venereol 14(6), 513\u20134 (2000).","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"53017_CR28","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1159\/000247420","volume":"185","author":"R Cecchi","year":"1992","unstructured":"Cecchi, R., Seghieri, G., Gironi, A., Tuci, F. & Giomi, A. Relation between urinary albumin excretion and skin involvement in patients with psoriasis. Dermatology 185(2), 93\u20135 (1992).","journal-title":"Dermatology"},{"issue":"1","key":"53017_CR29","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/00124743-200002000-00001","volume":"6","author":"IN Bruce","year":"2000","unstructured":"Bruce, I. N., Schentag, C. T. & Gladman, D. D. Hyperuricemia in psoriatic arthritis: prevalence and associated features. J Clin Rheumatol 6(1), 6\u20139 (2000).","journal-title":"J Clin Rheumatol"},{"issue":"6","key":"53017_CR30","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1046\/j.1365-2230.1998.00373.x","volume":"23","author":"M Kim","year":"1998","unstructured":"Kim, M., Ko, Y., Yeo, U. C., Kim, Y. & Oh, H. Psoriasis and glomerulonephritis. Clin Exp Dermatol 23(6), 295\u20136 (1998).","journal-title":"Clin Exp Dermatol"},{"key":"53017_CR31","first-page":"593170","volume":"2014","author":"CL Lang","year":"2014","unstructured":"Lang, C. L. et al. Correlation of interleukin-17-producing effector memory T cells and CD4+CD25+Foxp3 regulatory T cells with the phosphate levels in chronic hemodialysis patients. ScientificWorldJournal 2014, 593170 (2014).","journal-title":"ScientificWorldJournal"},{"issue":"7","key":"53017_CR32","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.ad.2013.01.003","volume":"104","author":"G Carretero","year":"2013","unstructured":"Carretero, G. et al. Guidelines for the use of acitretin in psoriasis. Psoriasis Group of the Spanish Academy of Dermatology and Venereology. Actas Dermosifiliogr 104(7), 598\u2013616 (2013).","journal-title":"Actas Dermosifiliogr"},{"issue":"1","key":"53017_CR33","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1159\/000330330","volume":"223","author":"P Quaglino","year":"2011","unstructured":"Quaglino, P. et al. Th1, Th2, Th17 and regulatory T cell pattern in psoriatic patients: modulation of cytokines and gene targets induced by etanercept treatment and correlation with clinical response. Dermatology 223(1), 57\u201367 (2011).","journal-title":"Dermatology"},{"issue":"6","key":"53017_CR34","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s00403-012-1229-1","volume":"304","author":"SB Yilmaz","year":"2012","unstructured":"Yilmaz, S. B., Cicek, N., Coskun, M., Yegin, O. & Alpsoy, E. Serum and tissue levels of IL-17 in different clinical subtypes of psoriasis. Arch Dermatol Res 304(6), 465\u20139 (2012).","journal-title":"Arch Dermatol Res"},{"issue":"3","key":"53017_CR35","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.pathol.2017.01.003","volume":"49","author":"C Cortvrindt","year":"2017","unstructured":"Cortvrindt, C., Speeckaert, R., Moerman, A., Delanghe, J. R. & Speeckaert, M. M. The role of interleukin-17A in the pathogenesis of kidney diseases. Pathology 49(3), 247\u201358. (2017).","journal-title":"Pathology"},{"issue":"2","key":"53017_CR36","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.imlet.2011.10.002","volume":"141","author":"BH Chung","year":"2012","unstructured":"Chung, B. H. et al. Increased interleukin-17 producing effector memory T cells in the end-stage renal disease patients. Immunol Lett 141(2), 181\u20139 (2012).","journal-title":"Immunol Lett"},{"issue":"1","key":"53017_CR37","doi-asserted-by":"publisher","first-page":"e54895","DOI":"10.1371\/journal.pone.0054895","volume":"8","author":"T Furuhashi","year":"2013","unstructured":"Furuhashi, T. et al. Photo(chemo)therapy reduces circulating Th17 cells and restores circulating regulatory T cells in psoriasis. PLoS One 8(1), e54895 (2013).","journal-title":"PLoS One"},{"key":"53017_CR38","doi-asserted-by":"crossref","unstructured":"Priyadarssini, M., Chandrashekar, L. & Rajappa, M. Effect of methotrexate monotherapy on T-cell subsets in the peripheral circulation in psoriasis. Clin Exp Dermatol (2018).","DOI":"10.1111\/ced.13795"},{"issue":"3","key":"53017_CR39","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1046\/j.1365-2133.1998.02122.x","volume":"138","author":"AV Powles","year":"1998","unstructured":"Powles, A. V. et al. Renal function after 10 years\u2019 treatment with cyclosporin for psoriasis. Br J Dermatol 138(3), 443\u20139 (1998).","journal-title":"Br J Dermatol"}],"updated-by":[{"DOI":"10.1038\/s41598-020-59024-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,2,5]],"date-time":"2020-02-05T00:00:00Z","timestamp":1580860800000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-53017-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-53017-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-53017-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T10:54:17Z","timestamp":1671274457000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-53017-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,12]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["53017"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-53017-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,12]]},"assertion":[{"value":"13 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2020","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An amendment to this paper has been published and can be accessed via a link at the top of the paper.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16581"}}